MAIA Biotechnology Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2025 Annual Meeting ...

(NYSE American: MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company focused on developing targeted ...

CHICAGO, October 15, 2024--MAIA Biotechnology Announces Poster Presentation of Novel THIO Prodrugs at ENA 2024 Symposium on Molecular Targets and Cancer Therapeutics ...

PanGIA Biotech Announces Upcoming ASCO 2025 Poster Presentation of Collaborative Research. PanGIA Biotech, a company advancing urine-based, AI-driven diagnostics for early cancer detection, today ...

Annual Biotechnology, Systems, and Synthetic Biology Poster Fair: This event will be held in the Spring Quarter at a venue located at the Chicago campus, at which students and postdocs will have the ...

MAIA Biotechnology, Inc.,, ... that a late-breaking abstract detailing new updates from its Phase 2 THIO-101 clinical trial was selected for oral and poster ... a category reserved for research ...

MAIA Biotechnology Announces Poster Presentation at ESMO's European Lung Cancer Congress 2025. ... from our research and data to our policies on content and your personal data. We’d ...

MAIA Biotechnology Announces Poster Presentation of Novel THIO Prodrugs at ENA 2024 Symposium on Molecular Targets and Cancer Therapeutics Contacts Investor Relations Contact +1 (872) 270-3518 ir ...

MAIA Biotechnology Announces Poster Presentation of Novel THIO Prodrugs at ENA 2024 Symposium on Molecular Targets and Cancer Therapeutics Oct. 15, 2024 8:15 AM ET MAIA Biotechnology, Inc. (MAIA) ...